References - CardioChek PLUS User Manual

X.

References

1. ATP III NCEP Guidelines for CHD Risk. JAMA. 2001. 285:2486-2509.
2. Castelli, WP, et al. Circulation 1983. 67(4): 730-734.
3. Clinical Diagnosis and Management by Laboratory Methods, Eighteenth Edition, John
Bernard Henry, Editor, W.B. Saunders Company, Philadelphia, 1991.
4. Friedewald et al. Clin Chem. 1972. 18(6):499-502.
5. National Cholesterol Education Program 2001 Guidelines, National Institutes of Health,
National Heart, Lung and Blood Institute, May, 2001.
6. Tietz, NW. Textbook of Clinical Chemistry, W.B. Saunders Co., Philadelphia, PA 1986, pp.
1271-1279, 1821.
7. Young, DL, et. al., Effects of Drugs on Clinical Laboratory Tests, AACC Press, Wash., D.C.,
1990.
8. Data on file, Polymer Technology Systems, Inc. Indianapolis, IN 46268.
9. CLSI Guideline EP6, Evaluation of the Linearity of Quantitative Analytical Methods.
Villanova, PA. National Committee for Clinical Laboratory Standards, 1986.
10. CLSI Guideline EP7, Interference Testing in Clinical Chemistry. Villanova, PA. National
Committee for Clinical Laboratory Standards, 1986.
11. Tietz, NW. Textbook of Clinical Chemistry, W.B. Saunders Co., Philadelphia, PA 1987.
15